Norris Medicines Limited (NORRIS.BO)
INR 17.36
(0.75%)
INR 17.36
(0.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 214.86 Million INR | 0.48% |
| 2022 | 213.84 Million INR | 1.55% |
| 2021 | 210.58 Million INR | 14.67% |
| 2020 | 183.64 Million INR | 2.85% |
| 2019 | 178.55 Million INR | 26.28% |
| 2018 | 141.39 Million INR | 26.13% |
| 2017 | 112.1 Million INR | -0.18% |
| 2016 | 112.3 Million INR | 47.38% |
| 2015 | 76.2 Million INR | -4.3% |
| 2014 | 79.62 Million INR | 10.35% |
| 2013 | 72.15 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 376 Thousand INR | -99.83% |
| 2023 Q4 | 214.86 Million INR | 99835.35% |
| 2023 Q2 | 215.16 Million INR | 105894.09% |
| 2023 FY | 214.86 Million INR | 0.48% |
| 2023 Q3 | 215 Thousand INR | -99.9% |
| 2023 Q1 | 203 Thousand INR | -99.91% |
| 2022 Q4 | 213.84 Million INR | 114867.97% |
| 2022 Q3 | 186 Thousand INR | -99.91% |
| 2022 Q2 | 214.86 Million INR | 115416.05% |
| 2022 Q1 | 186 Thousand INR | -99.91% |
| 2021 Q3 | 204 Thousand INR | -99.9% |
| 2021 Q2 | 200.72 Million INR | 1395.37% |
| 2021 Q1 | 13.42 Million INR | -92.69% |
| 2021 Q4 | 210.58 Million INR | 103127.71% |
| 2020 Q1 | 6.75 Million INR | -96.22% |
| 2020 Q4 | 183.64 Million INR | 2182.17% |
| 2020 Q3 | 8.04 Million INR | -95.61% |
| 2020 Q2 | 183.28 Million INR | 2612.95% |
| 2019 Q4 | 178.55 Million INR | 1814.36% |
| 2019 Q2 | 156.49 Million INR | 2380.47% |
| 2019 Q1 | 6.3 Million INR | -95.54% |
| 2019 Q3 | 9.32 Million INR | -94.04% |
| 2018 Q4 | 141.39 Million INR | 2103.84% |
| 2018 Q3 | 6.41 Million INR | -95.07% |
| 2018 Q2 | 130.25 Million INR | 0.0% |
| 2017 Q4 | 112.1 Million INR | 8955.05% |
| 2017 Q2 | 102.39 Million INR | 21902.46% |
| 2017 Q1 | 465.35 Thousand INR | -99.59% |
| 2017 Q3 | 1.23 Million INR | -98.79% |
| 2016 Q1 | -1.07 Million INR | -101.41% |
| 2016 Q4 | 112.3 Million INR | 4030.43% |
| 2016 Q3 | 2.71 Million INR | -96.58% |
| 2016 Q2 | 79.44 Million INR | 7483.19% |
| 2015 Q2 | 73.41 Million INR | 0.0% |
| 2015 Q3 | 3.18 Million INR | -95.66% |
| 2015 Q4 | 76.2 Million INR | 2291.72% |
| 2014 Q1 | 3.1 Million INR | 0.0% |
| 2014 Q4 | 79.62 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Sunil Healthcare Limited | 625.4 Million INR | 65.644% |
| ANG Lifesciences India Limited | 671.01 Million INR | 67.98% |
| BDH Industries Limited | -164.47 Million INR | 230.639% |
| Deccan Health Care Limited | -7.07 Million INR | 3136.482% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 330.692% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 498.748% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -752.174% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 546.716% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 127.132% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 50.232% |
| MedPlus Health Services Limited | 8.67 Billion INR | 97.524% |
| Patidar Buildcon Limited | 25.12 Million INR | -755.136% |
| Add-Shop E-Retail Limited | 116.24 Million INR | -84.83% |
| Bacil Pharma Limited | 569 Thousand INR | -37661.239% |
| Beryl Drugs Limited | 48.7 Million INR | -341.121% |
| Cian Healthcare Limited | 544.97 Million INR | 60.574% |
| Concord Drugs Limited | 164.48 Million INR | -30.625% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 349.984% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -468.958% |
| Sastasundar Ventures Limited | -297.24 Million INR | 172.283% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 2407.857% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 466.745% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 79.477% |
| Syschem (India) Limited | 3.53 Million INR | -5983.28% |
| Medi-Caps Limited | -3.21 Million INR | 6785.173% |
| Parmax Pharma Limited | 51.8 Million INR | -314.711% |
| Smruthi Organics Limited | 111.28 Million INR | -93.066% |
| Phaarmasia Limited | -4.89 Million INR | 4487.614% |
| Transchem Limited | -3.16 Million INR | 6892.964% |
| Trinity League India Limited | -12 Thousand INR | 1790612.083% |
| Tyche Industries Limited | -788.94 Million INR | 127.234% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -172.999% |
| Zenith Healthcare Limited | -25.45 Million INR | 944.017% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 3646.739% |
| Colinz Laboratories Limited | -64.3 Million INR | 434.139% |
| Denis Chem Lab Limited | -236.28 Million INR | 190.933% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 76.69% |
| Makers Laboratories Limited | 172.59 Million INR | -24.492% |
| Panchsheel Organics Limited | -157.82 Million INR | 236.142% |
| Parnax Lab Limited | 787.61 Million INR | 72.72% |
| PRAVEG LIMITED | -434.98 Million INR | 149.395% |
| Mercury Laboratories Limited | -26.72 Million INR | 903.851% |
| Trident Lifeline Limited | 117.56 Million INR | -82.767% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -456.276% |
| Vivanza Biosciences Limited | 50.02 Million INR | -329.5% |
| Zenlabs Ethica Limited | 139.54 Million INR | -53.972% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 581.493% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 382.144% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 68.833% |
| Roopa Industries Limited | 216.01 Million INR | 0.534% |
| PANJON LTD. | -12.8 Million INR | 1777.557% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -476.221% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -1498.077% |
| Anuh Pharma Limited | -69.8 Million INR | 407.794% |
| Crestchem Limited | -1.45 Million INR | 14918.031% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 453.786% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 1979.803% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 79.419% |
| Trimurthi Limited | -1.17 Million INR | 18336.416% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 414.746% |
| Veerhealth Care Limited | -2.38 Million INR | 9108.866% |
| Lactose (India) Limited | 373.97 Million INR | 42.546% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 62.393% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | -62.651% |
| Gennex Laboratories Limited | -552.54 Million INR | 138.886% |
| Godavari Drugs Limited | 530.02 Million INR | 59.462% |
| Zenotech Laboratories Limited | -196.85 Million INR | 209.146% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | -6.442% |
| Bharat Parenterals Limited | 1.48 Billion INR | 85.567% |
| Coral Laboratories Limited | -612.82 Million INR | 135.061% |
| Evoq Remedies Limited | 41.14 Million INR | -422.167% |
| Kerala Ayurveda Limited | 447.82 Million INR | 52.021% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 84.599% |
| Natural Capsules Limited | 956.68 Million INR | 77.541% |
| Auro Laboratories Limited | 252.51 Million INR | 14.912% |